Abstract
Myotonic dystrophy type 1 (DM1) has been identified as the amplification of a polymorphic (CTG)n repeat in the 3′ untranslated region of a gene encoding a serine/threonine kinase (DMPK). The length of the CTG repeat correlates with clinical severity and the age at onset of the disease. Thus, the ability to perform quick and accurate molecular genetic diagnoses is of great importance to patients and their families. Polymerase chain reaction (PCR) and Southern blots are essential methods for such diagnoses. All previously published methods are based on Southern blots using radioactive probes. Furthermore, the enzymes used for DNA digestion result in larger fragments, which makes it difficult to accurately determine the insert sizes. In this study, we report an improved method for molecular diagnosis of DM1. This method employs an initial screening with PCR followed by Southern blots using nonradioactive probes and TaqI as the enzyme, and provides a much better resolution of the labeled bands. J. Clin. Lab. Anal. 18:50–54, 2004. © 2004 Wiley‐Liss, Inc.
Keywords: DM1, molecular diagnosis, myotonic dystrophy, nonradioactive method
REFERENCES
- 1. Akbas F, Serdaroglu P, Deymeer F, Aysal F, Erginel‐Unaltuna N. Molecular and clinical study of two myotonic dystrophy homozygotes. J Med Genet 2001;38:E40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799–808. [DOI] [PubMed] [Google Scholar]
- 3. Fu YH, Pizzuti A, Fenwick RG Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256–1258. [DOI] [PubMed] [Google Scholar]
- 4. Hamshere MG, Harley H, Harper P, Brook JD, Brookfield JF. Myotonic dystrophy: the correlation of (CTG) repeat length in leucocytes with age at onset is significant only for patients with small expansions. J Med Genet 1999;36:59–61. [PMC free article] [PubMed] [Google Scholar]
- 5. Harper PS. Myotonic dystrophy. 2nd ed. Philadelphia: W.B. Saunders; 1989. 331 p. [Google Scholar]
- 6. Hecht BK, Donnelly A, Gedeon AK, Byard RW, Haan EA, Mulley JC. Direct molecular diagnosis of myotonic dystrophy. Clin Genet 1993;43:276–285. [DOI] [PubMed] [Google Scholar]
- 7. Lavedan C, Hofmann‐Radvanyi H, Shelbourne P, et al. Myotonic dystrophy: size and sex‐dependent dynamics of CTG meiotic instability and somatic mosaicism. Am J Hum Genet 1993;52:875–883. [PMC free article] [PubMed] [Google Scholar]
- 8. Marchini C, Lonigro R, Verriello L, Pellizzari L, Bergonzi P, Damante G. Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 2000;57:74–82. [DOI] [PubMed] [Google Scholar]
- 9. Martorell L, Illa I, Rosell J, Benitez J, Sedano MJ, Baiget M. Homozygous myotonic dystrophy: clinical and molecular studies of three unrelated cases. J Med Genet 1996;33:783–785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Shelbourne P, Davies J, Buxton J, et al. Direct diagnosis of myotonic dystrophy with a disease‐specific DNA marker. N Engl J Med 1993;328:471–475. [DOI] [PubMed] [Google Scholar]
- 11. International Myotonic Dystrophy Consortium (IDMC) . New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 2000;54:1218–1221. [DOI] [PubMed] [Google Scholar]
- 12. Wong LJ, Ashizawa T, Monckton DG, Caskey CT, Richards CS. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet 1995;56:114–122. [PMC free article] [PubMed] [Google Scholar]